Mandate

Vinge advises the founders in connection with Polaris’ investment in Distriktstandvården

September 01, 2020 Employment and Benefits M&A

Vinge advises the founders of Distriktstandvården Ibbe Gnem and Jan Lindqvist in connection with Polaris’ investment in the company.

Distriktstandvården is the leading independent private dentistry chain in the greater Stockholm region. In addition to general, emergency and aesthetic dentistry services, Distriktstandvården offers specialist dental care as well as mobile and anaesthesia treatments. Following the investment, Polaris becomes a co-owner of Distriktstandvården alongside its founders who founded the company in 2010.

Vinge’s team consisted of Jonas Johansson, Matthias Pannier, Carl Sander, Nina Gransäter and Hanna Risberg (M&A), Ebba Svenburg (Employment), and VDR-specialists Jessica Öijer and Christoffer Widström.

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024